# Commission Regulation (EU) 2018/1556 of 17 October 2018 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (Text with EEA relevance), Annex: Rejected health claim

Extent: E+W+S+N.I.

Application — Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Stablor®, a drink preparation with defined macro- and micronutrient composition and specific proportion of amino acids (tryptophan to neutral amino acids ratio)
In the context of a well-balanced diet and a mild caloric restriction, the addition of Stablor® contributes to decrease visceral fat while preserving lean mass in overweight or obese subjects with abdominal fat and cardiometabolic risk factors.
Q-2016-00319
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Curcumin
Curcumin contributes to the normal functioning of joints.
Q-2016-00856
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
A carbohydrate:protein (CHO:P) ratio ≤ 1.8 on an energy basis in the context of an energy-restricted diet and body weight
Helps to achieve a reduction in body weight and body fat when consumed as part of an energy restricted diet (< 8 368 kJ/2 000 kcal/day) for a minimum of 12 weeks.
Q-2016-00436
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Vibigaba (germinated brown rice)
In the context of an energy-restricted diet contributes to weight loss.
Q-2017-00032
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Vibigaba (germinated brown rice)
Contributes to the maintenance of normal blood glucose levels.
Q-2017-00033
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Vibigaba (germinated brown rice)
Contributes to the maintenance of normal blood pressure.
Q-2017-00031
Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data
Vibigaba (germinated brown rice)
Contributes to the maintenance of normal blood cholesterol levels.
Q-2017-00030

---
Source: https://www.legislation.gov.uk/eur/2018/1556/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2018-1556/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.